CN1390549A - Medicine for treating beriberi - Google Patents
Medicine for treating beriberi Download PDFInfo
- Publication number
- CN1390549A CN1390549A CN 02132678 CN02132678A CN1390549A CN 1390549 A CN1390549 A CN 1390549A CN 02132678 CN02132678 CN 02132678 CN 02132678 A CN02132678 A CN 02132678A CN 1390549 A CN1390549 A CN 1390549A
- Authority
- CN
- China
- Prior art keywords
- grams
- medicine
- penicillin
- medicament
- benzoic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
An exterior-applied medicine for treaitng beriberi is prepared from alcohol, salicylic acid, benzoic acid, penicillin and rivanol through mixing. Its advantages are short course of treatment (3-5 days), high cure rate (100%), and no toxic by-effect.
Description
(1) technical field
The present invention relates to a kind of medicine, especially relate to the beriberic medicament of a kind of treatment.
(2) background technology
" beriberi " medically is tinea pedis, caused by the superficial part pathomycete.Every summer and autumn, the people who suffers from " beriberi " is just many especially, and this is because the environment of warm moist for the conk breeding provides good condition, adds is perspired many and the increase of foot metabolism, just suffers from " beriberi " easily or " beriberi " increased the weight of." beriberi " looks it is minor illness, yet very itches sometimes and influence study and work, but secondary infection serious harm health can self infect simultaneously and cause the tinea manuum, tinea corporis and tinea unguium, even also can infect other people.Suffering from " beriberi " person may all have cognition, and the situation of each outbreak is all different.Summer and autumn is mainly based on squama vesicle type and dipping erosive type.Squama vesicle type is the most common, is everlasting between toe, syringe needle size pimple and herpes appear in the sufficient sole of the foot and lateral margin repeatedly thereof, assembles or is dispersed in, in various degree inflammatory reaction and pruritus are arranged, and bleb is done the back desquamation, is little eckband shape or large stretch of shape, constantly come off, constantly take place, only show as the master sometimes with desquamation; The dipping erosive type is common between the 4th, the 5th toe, and horny layer floods, turns white, soft, exposes red rotten to the corn face or honeycomb substrate after stripping off, and a little sepage can be arranged, this kind of easy secondary infection, concurrent acute lymphangitis, erysipelas etc.At present, the beriberic medicine of treatment is a lot of on the market, though the treatment vitamin B1 deficiency is had better curative effect, cure rate is low, the long easily recurrence course of treatment.
(3) summary of the invention
The objective of the invention is provides a kind of short treating period at the problems referred to above, and curative effect is obvious, the beriberic combination medicament of the treatment that cure rate is high.
The present invention is achieved by the following technical solution: promptly treat beriberic medicament and be made up of following medicine: salicylic acid, molecular formula are C
6H
4(OH) COOH, content 99.5%, benzoic acid, molecular formula is C
7H
6O
2, content is no less than 99.5%, penicillin, 500 milliliters of content 0.1% of rivanoli solution, alcohol concentration 90%.Its concrete composition by weight is:
Ethanol: 50 weight portions
Salicylic acid: 8-12 weight portion
Benzoic acid: 3-5 weight portion
Penicillin: 3-5 weight portion
Ethacridine: 3-5 weight portion
Manufacture method of the present invention is: will claim according to the above ratio salicylic acid, benzoic acid, the penicillin made to put into container, and ethacridine be added in the container at normal temperatures and pressures again that put into ethanol at last, stirring is hybridly prepared into.
Medicament of the present invention is wiped the examination external through 50 patients, through 3 days courses of treatment, cures 45 people, and total effective rate reaches 100%, and cure rate reaches 90%, and radical cure person 25 people reach 50%.
Reach 100%, 50 people through two course of therapy healing persons and all fully recover, radical cure person 43 people reach 85%, no longer recurrence, and this medicine has no side effect.
The present invention compared with prior art has following advantage and good effect:
1, through part patient probationary certificate short treating period of the present invention, the external obliterating is wiped with 3 days continuously in the affected part, can cure, and curative effect is obvious, cure rate is high, total effective rate 100%.Through treatment in 3 days, effecting a radical cure no longer, the recidivist can reach 50%.
2, summer through 3 days course of therapy, all the other 50% not also no longer recurrences at least 2 months of radical cure person, heavy patient adheres to a week treatment, radical cure person can reach 85%.
(4) specific embodiment
Embodiment one
Treat beriberic medicament by ethanol 500 grams, salicylic acid 120 grams, benzoic acid 40 grams, penicillin 45 grams, ethacridine 45 grams.At first salicylic acid, benzoic acid, penicillin are put into container, ethacridine is added in the container at normal temperatures and pressures again, it is clear to put into wine at last, and stirring gets final product, and makes this medicament.
Embodiment two
Treat beriberic medicament by ethanol 500 grams, salicylic acid 100 grams, benzoic acid 50 grams, penicillin 50 grams, ethacridine 50 grams, at first salicylic acid, benzoic acid, penicillin is put into container, at normal temperatures and pressures, again ethacridine is added in the container, put into ethanol at last, stir, promptly can be made into this medicament.
Claims (2)
1, treat beriberic medicament, it is characterized in that this medicine is by ethanol 50 weight portions, salicylic acid: 8-12 weight portion, benzoic acid: 3-5 weight portion, penicillin 3-5 weight portion, ethacridine: the 3-5 weight portion is hybridly prepared into.
2, the beriberic medicament of treatment according to claim 1 is characterized in that this medicine is by: ethanol 500 grams, salicylic acid 100 grams, and benzoic acid 50 grams, penicillin 50 grams, ethacridine 50 grams are hybridly prepared into.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 02132678 CN1390549A (en) | 2002-07-26 | 2002-07-26 | Medicine for treating beriberi |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 02132678 CN1390549A (en) | 2002-07-26 | 2002-07-26 | Medicine for treating beriberi |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1390549A true CN1390549A (en) | 2003-01-15 |
Family
ID=4746882
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 02132678 Pending CN1390549A (en) | 2002-07-26 | 2002-07-26 | Medicine for treating beriberi |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1390549A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101940648A (en) * | 2009-07-09 | 2011-01-12 | 唐显 | Medicament for quickly and radically curing barbiers |
| CN104367607A (en) * | 2014-11-27 | 2015-02-25 | 桂林瑞丰环保微生物应用研究所 | Pharmaceutical formula for treating beriberi |
-
2002
- 2002-07-26 CN CN 02132678 patent/CN1390549A/en active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101940648A (en) * | 2009-07-09 | 2011-01-12 | 唐显 | Medicament for quickly and radically curing barbiers |
| CN104367607A (en) * | 2014-11-27 | 2015-02-25 | 桂林瑞丰环保微生物应用研究所 | Pharmaceutical formula for treating beriberi |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6495183B2 (en) | Compositions and methods for treating surface wounds | |
| CN113332162A (en) | protamine-PDRN compound, composition and application in preparation of skin care product | |
| Gayratovna | WAYS OF OPTIMIZATION OF LOCAL THERAPY FOR PURULENT-INFLAMMATORY DISEASES OF THE MAXILLOFAQIAL REGION | |
| RU2470640C1 (en) | Agent for treating inflammatory oral diseases and method of treating inflammatory oral diseases | |
| CN111514161B (en) | Anti-oral ulcer preparation and application thereof | |
| CN1210063C (en) | Complex local medicine for mainly treating oral ulcer | |
| CN1390549A (en) | Medicine for treating beriberi | |
| RU2405534C1 (en) | Anti-acne cream gel | |
| WO2022150716A1 (en) | Methods of treating wounds and burns | |
| CN107158051A (en) | Tannic acid ointment for treating eczema and preparation method thereof | |
| US8900601B2 (en) | Permeable mixtures, methods and compositions for the skin | |
| CN112791093A (en) | Transdermal drug delivery composition for treating acne and preparation method thereof | |
| CN1199666C (en) | Medicine 'Suyusan' for treating intractable ulcer | |
| CN1182852C (en) | Medicine for curing dermatosis | |
| Chartkitcharoen et al. | Effectiveness of 1% Silver Sulfadiazine with Zinc versus 1% Silver Sulfadiazine in Burn Wound Healing. | |
| US20030092682A1 (en) | Use of doxycycline for treatment of certain skin and mouth ailments | |
| CN1172678C (en) | Itch-tinea mixture | |
| RU2789515C1 (en) | Pharmaceutical composition based on aqua-complex of titanium glycerosolvate in combination with l-arginine for treatment of inflammatory diseases of oral mucosa | |
| RU2797139C1 (en) | Self-hardening gel for the treatment of necrotic ulcer diseases of the periodontal and mucosa of the oral cavity | |
| CN1086125C (en) | Externally used medicine for treating tinea | |
| RU2710541C1 (en) | Method of treating angular cheilitis caused by deficiency of riboflavin | |
| CN106955291A (en) | A kind of anti-inflammation medicament and preparation method thereof | |
| CN112933174A (en) | External application preparation for bedsore and old rotten leg and preparation method thereof | |
| Wynn et al. | Case report: wound care of a diabetic foot ulcer | |
| MCPS et al. | Effectiveness of 0.025% Dakin’s Solution Versus 1% Silver Sulphadiazine for Treatment of Partial Thickness Burns |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |